<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Niemeyer</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zillinger</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Muth</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zielecki</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Horvath</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Suliman</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2013</year>). 
  <article-title>Middle east respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist</article-title>. 
  <source>J. Virol.</source>
  <volume>87</volume>, 
  <fpage>12489</fpage>â€“
  <lpage>12495</lpage>. 
  <pub-id pub-id-type="doi">10.1128/jvi.01845-13</pub-id>
  <?supplied-pmid 24027320?>
  <pub-id pub-id-type="pmid">24027320</pub-id>
 </mixed-citation>
</ref>
